By Iain Gilbert
Date: Tuesday 06 May 2025
(Sharecast News) - Chemicals business Synthomer has agreed to divest William Blythe, its inorganic chemistry business, to its management team and H2 Equity Partners for £30.0m.
Synthomer said on Tuesday that the sale of William Blythe, which was conditional on certain customary closing conditions, was expected to complete at the end...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news